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Mothers of children diagnosed with cancer are faced with numerous, prolonged stressors 
that can negatively impact their psychosocial functioning and thus their health. Consequently, 
identifying potential risk or health protective factors may be especially important for this 
population. In this regard, a growing number of studies suggest that individual differences in the 
use of emotion regulation strategies, such as expressive suppression and cognitive reappraisal, 
may modulate the negative emotional consequences of chronic/prolonged stressors. Though 
limited and cross-sectional in nature, studies have also started examining associations between 
emotion regulation strategies of suppression and reappraisal with inflammation—an important 
biomarker implicated in numerous immune-mediated illnesses, including cardiovascular disease. 
The main objective of the present study is to extend extant findings to a prospective examination 
of whether the use of emotion suppression and cognitive reappraisal influence symptoms of 
distress and inflammation among mothers of children recently diagnosed with cancer (N=120). 
In the present study, inflammation was indexed by circulating and stimulated levels of IL-6. 
Mothers were followed from approximately one month of their child’s diagnosis (T1) to twelve 
months post-diagnosis. Results showed a decrease in level of distress and an increase in 
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circulating and stimulated measures of inflammation across the follow-up period. Higher self-
reported use of reappraisal related to lower levels of distress at T1; however, it did not 
significantly predict rate of change in distress over time. Similarly, higher self-reported use of 
suppression related to higher levels of distress at T1, but it did not predict rate of change in 
distress level across the follow-up period. In regard to inflammation, reappraisal did not relate to 
initial levels or change in circulating or stimulated levels of IL-6. While we also did not observe 
a significant association between suppression and initial circulating or stimulated IL-6, 
suppression did predict significantly slower increases in stimulated IL-6 levels. A similar 
tendency was observed on analysis of circulating IL-6. Implications of these findings and future 
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Mothers of children diagnosed with cancer are confronted with an intense and prolonged 
stressful life experience that is marked by not only a threat to their child’s life but also significant 
disruption in their life due to numerous additional demands (e.g., taking their child to frequent 
hospital and clinic visits) and often to marital and financial strain (Long & Marsland, 2011). A  
review by Vrijmoet-Wiersma and colleagues (2008) examining the psychological and emotional 
adjustment of this population has shown that during the period immediately following their 
child’s diagnosis, most mothers report a range of negative emotions including feelings of 
depression, anxiety, anger and guilt. While these symptoms gradually alleviate, for a subset of 
mothers these symptoms persist, which may be detrimental to both physical and mental health 
(Vrijmoet-Wiersma et al., 2008). While these intense feelings gradually decrease for most, a 
subset of mothers show persistent emotional distress, which may be detrimental to both physical 
and mental health (Vrijmoet-Wiersma et al., 2008). Consequently, recent attention has focused 
on risk and protective factors that can identify vulnerable individuals and be targeted through 
early intervention. In this regard, individual differences in strategies used to regulate emotions 
contribute to emotional adjustment and thus health outcomes among this population. Most 
existing studies examining associations of emotion regulation strategy use with distress and 
health factors are cross-sectional and examine undergraduate or non-stressed populations. 
Despite theoretical hypotheses that these strategies modify emotional experiences, to date, no 
longitudinal studies have examined the association of dispositional differences in use of emotion 
regulation strategies with distress among a population confronting an extremely stressful life 
event.  For this reason, the present study examines prospective associations of the emotion 
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regulation strategies of reappraisal and suppression with distress and inflammation, a marker of 
physical health risk, among mothers of children newly diagnosed with cancer. 
1.1 NEGATIVE HEALTH CONSEQUENCES OF PROLONGED NEGATIVE 
EMOTIONS 
There is evidence that prolonged negative emotional states such as depression, anxiety, 
and anger that often accompany chronic stressors predict negative health outcomes, in particular 
the onset and progression of immune-mediated diseases including cardiovascular disease (CVD) 
(e.g., Everson-Rose & Lewis, 2005; Kiecolt-Glaser et al., 2002; Kubzansky & Kawachi, 2000; 
Joynt, Whellan, & O’Connor, 2003; Suls & Bunde, 2005). Pathways linking negative emotions 
to poor health outcomes remain unclear and are likely complex. However, growing evidence 
suggests that behavioral and physiological mechanisms play a role.   
Behaviorally, emotionally demanding experiences are often accompanied by lifestyle 
changes such as increased substance abuse, decreased levels of physical activity, dietary 
changes, and sleep disruptions that may contribute to increased health risk in the face of chronic 
stress (Kiecolt-Glaser et al., 2002; Cohen, Janicki-Deverts, & Miller, 2007). Physiologically, 
negative emotional states are associated with central nervous system changes that result in the 
activation of peripheral physiological pathways.  More specifically, limbic brain regions (e.g., 
amygdala or the anterior cingulate) that are activated in response to negative emotion eliciting 
situations have direct neural projections to brain stem areas, such as the nucleus tractus solitaries 
(NTS), or other limbic areas, such as the hypothalamus, that modulate peripheral physiological 
activity. In this regard, two interconnected central-to-peripheral pathways have been identified 
that play a role in the physiological consequences of stressful experiences: the autonomic 
nervous system (ANS) and the hypothalamic-pituitary-adrenal (HPA) axis.   
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1.1.1 The ANS 
The ANS is divided into two subsystems: the sympathetic system (SNS) and the 
parasympathetic nervous system (PsNS). Activation of the SNS is associated with arousal and 
promotes a “flight or fight” response, preparing the body for activity by mobilizing energy and 
inhibiting digestion. Conversely, the PsNS is referred to as the “rest-and-digest” system that 
generally acts to preserve energy. These two branches of the ANS can act independently, 
reciprocally, or non-reciprocally (e.g., in a coactivating or coinhibiting manner; Berntson, 
Cacioppo, & Quigley, 1991, 1993) in regulating body systems and the allocation of metabolic 
resources to meet environmental demands.  There is evidence, using pharmacological blockades 
and noninvasive indices of autonomic control, that negative emotional states, such as those 
evoked during acute psychosocial challenges (e.g., evaluative speech or mental arithmetic tasks) 
are characterized by a predominantly reciprocal alterations in activation of the two branches of 
the ANS, with increases in SNS and decreases in PsNS output resulting in peripheral changes 
(e.g., Berntson et al., 1994; Berntson, Cacioppo, & Fieldstone, 1996). There is also evidence that 
chronic negative emotional experiences, such as depression and various anxiety disorders, are 
characterized by similar alterations in activation of the two branches of the ANS, with increases 
in SNS and decreases in PsNS activity (Carney, Freedland, & Veith, 2005; Friedman, 2007; 
Rottenberg, 2007). This pattern of autonomic activation (i.e., greater SNS activity and/or lower 
PsNS activity), often referred to as autonomic dysregulation or dysfunction, has been shown to 
associate with increased risk for hypertension and CVD (e.g., Erdogan et al., 2011).   
1.1.2 The HPA axis 
The HPA axis can be characterized as an integrated system that begins with the release of 
corticotropic-releasing hormone from the paraventricular nucleus of the hypothalamus, 
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stimulating the release of adrenocorticotropic hormone from the anterior pituitary gland, which 
in turn results in the synthesis and release of glucocorticoid from the adrenal gland. In humans, 
the predominant glucocorticoid is cortisol. Stressful experiences result in activation of the HPA 
axis and peripheral release of cortisol. Furthermore, certain pro-inflammatory cytokines, such as 
IL-6, also stimulate the production of corticotropic-releasing hormone. Cortisol influences 
several physiologic systems, including metabolic and immune systems, and has been implicated 
in CVD risk (Walker, 2007). Both the ANS and the HPA axis modulate peripheral levels of 
inflammation, an accepted marker of risk for incident chronic inflammatory diseases, such as 
CVD.  
1.2 INFLAMMATION AS A PATHWAY LINKING PROLONGED NEGATIVE 
EMOTIONS TO INCREASED HEALTH RISK 
It is well-established that stress relates to increased circulating and stimulated levels of 
inflammatory markers, which may contribute to increased physical health risk (Kiecolt-Glaser et 
al., 2002; Sergerstrom & Miller, 2004). The inflammatory process is often defined as a non-
specific, first line of defense reaction that is initiated when immune cells such as monocytes (or 
macrophages) detect tissue damage or the presence of invading pathogens.  Local and systemic 
inflammatory responses are promoted through the release of pro-inflammatory cytokines, such as 
interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α. These inflammatory responses also 
involve the synthesis and release of acute phase proteins, such as C-reactive protein (CRP) and 
fibrinogen, which in turn bind to damage tissues or pathogenic organisms further promoting pro-
inflammatory signaling. While adaptive in the short-term, prolonged elevation of systemic 
inflammation is implicated in the pathogenesis and course of immune-mediated illnesses such as 
CVD (Kaptoge et al., 2010).  
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The narrowing and hardening of blood vessels that is the primary cause of CVD results 
from progressive accumulation of plaque in vessel walls, termed atherosclerosis. A chronic 
inflammatory process underlies the development and progression of atherosclerosis that begins 
with damage to the endothelial lining of vessels, resulting in the infiltration of immune cells, 
platelets, lipids, and smooth muscle cells within the intima, the innermost layer of the vessel 
wall. Over time, this process results in the accumulation of cells and waste within the intima and 
the progressive narrowing of the artery, ultimately resulting in clinical CVD (Libby, Ridker, & 
Maseri, 2002; Steptoe & Brydon, 2009).  
The ANS and the HPA axis play a primary role in modulating the magnitude of 
peripheral inflammatory responses and thus provide potential peripheral pathways linking 
emotional experiences to risk for atherosclerosis. Activation of the SNS results in the peripheral 
release of catecholamines, such as epinephrine, from the adrenal medulla, which act on beta-
adrenergic receptors on immune cells to stimulate the expression and release of pro-
inflammatory mediators, leading to higher levels of these markers in circulation (Rohleder, 
2014).  Activation of the PsNS, on the other hand, triggers the release of acetylcholine via the 
vagus nerve, which binds to receptors on immune cells and down-regulates the inflammatory 
response (Tracey, 2002).  Similarly, activation of the HPA axis and the release of cortisol 
inhibits the production of pro-inflammatory cytokines by activating glucocorticoid receptors and 
decreasing pro-inflammatory cytokine gene expression. It is widely suggested that prolonged 
negative emotional experiences associate with chronic activation of the HPA axis, resulting in a 
downregulation of the sensitivity of cells to the actions of cortisol, which in turn maintains 
increased inflammation that may contribute to CVD morbidity (Miller, Chen, & Zhou, 2007; 
Cohen et al., 2012).  
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 In sum, negative emotional states, such as depression, that associate with increases in the 
ratio of SNS to PsNS activation or increased HPA activation may result in elevated or prolonged 
inflammatory responses that may contribute to the initiation and progression of the 
atherosclerotic process and thus CVD (Black & Garbutt, 2002; Dowlati et al., 2010; Miller & 
Blackwell, 2006; Rohleder, 2014). Therefore, effective regulation of negative emotional 
responses may play a role in CVD risk. 
1.3 EMOTION REGULATION STRATEGY USE AS A MODERATOR OF 
EMOTIONAL AND PHYSICAL OUTCOMES 
In the context of negative emotions, emotion regulation is broadly defined as the down-
regulation of emotional responses in order to facilitate an adaptive response to a situation (Gross, 
1998, 2013).  Generally, emotion regulatory strategies that are employed to regulate or manage 
emotional responses vary as a function of type of situation. However, evidence suggests that 
individuals show characteristic differences in emotion regulation strategy use that are stable 
across situations (Gross, 1998).  One of the most referenced theoretical models of emotion 
regulation is the process model of emotion regulation (Gross, 1998). The basic premise of this 
model is that emotion regulation strategies implemented early (referred to as antecedent-
focused), or before experiencing the ‘full’ extent of the emotion, require less effort and are more 
likely to alter the course of the entire emotional response than strategies implemented in the later 
stages of an emotional experience (referred to as response-focused). Thus, compared to response-
focused strategies, antecedent focused strategies may be more effective in downregulating 
negative emotions. 
To date, most of the research conducted referencing the process model of emotion 
regulation focuses on two specific strategies: reappraisal and expressive suppression. 
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‘Reappraisal’ is an antecedent-focused strategy that involves evaluating emotional stimuli from a 
more objective perspective by altering one’s thoughts and focus. For example, individuals who 
tend to engage in reappraisal typically endorse statements such as “when I’m faced with a 
stressful situation, I make myself think about it in a way that helps me stay calm” (from the 
Emotion Regulation Questionnaire, ERQ, Gross & John, 2003).  On the other hand, 
‘suppression’, which is categorized as a response-focused strategy, involves actively inhibiting 
the external expression of emotions as a way of downregulating internally experienced affect. 
Here, individuals who engage in suppression tend to agree with statements such as “when I am 
feeling negative emotions, I make sure not to express them” (ERQ, Gross & John, 2003). 
Consistent with theory, available evidence suggests that emotion suppression is less 
effective than reappraisal in downregulating a broad range of acutely experienced negative 
affect, as measured by self-report measures (see review by Webb, Miles, & Sheeran, 2012; 
Ehring et al., 2010). More specifically, the existing evidence highlights the relative 
ineffectiveness of emotion suppression and the possibility of long-term psychological 
consequences of its frequent use. For example, a growing literature suggests frequent use of 
emotion suppression relates to various psychological disorders including depression, anxiety, and 
eating and substance-related disorders, while the use of reappraisal may be protective against 
these disorders (see review by Aldao, Nolen-Hoeksema, & Schweizer, 2010).  Therefore, 
habitual use of emotion suppression may have long-term negative emotional consequences.  
Conversely, using reappraisal as an emotion regulation strategy may be health protective (John & 
Gross, 2004).  
However, to date, most of the studies that have examined the association between 
emotion regulation strategy and negative emotional states have been either cross-sectional or 
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primarily based on undergraduate student samples. Past studies have also focused on examining 
the association between emotion regulation strategy and negative emotions during acute stressors 
(e.g., laboratory stressors). As previously noted, the findings of these studies suggest that 
engaging in reappraisal may be more effective than suppression in downregulating negative 
affective responses (see review by Webb, Miles, & Sheeran, 2012). However, little is known 
about whether individual differences in emotion regulation strategy use relate prospectively to 
emotional adjustment among community populations experiencing chronic stress.  As a result, 
the first aim of the current study is to examine prospectively how the use of emotion suppression 
and reappraisal relate to symptoms of distress among mothers of children diagnosed with cancer. 
It is hypothesized that greater use of reappraisal will relate to lower distress at time of diagnosis 
and a faster decline in distress across twelve months post-diagnosis. Conversely, greater use of 
suppression will relate to higher distress at the time of diagnosis and a slower decrease in distress 
across the twelve months follow-up period.   
By moderating negative emotional responses to life’s challenges, it is possible that 
individual differences in emotion regulation strategy use may also contribute to emotion-related 
physical health risk.  In this regard, recent evidence relates emotion suppression to several 
behavioral factors implicated in disease risk.  For example, Appleton, Loucks, Buka, and 
Kubzanky (2014) found that in a large representative sample of middle-aged adults the use of 
suppression was associated with higher rates of smoking, alcohol consumption, and higher body 
mass index (BMI), compared to the use of reappraisal. Furthermore, in the same study, Appleton 
and colleagues showed that emotion suppression was associated with a 10% increase in CVD 
risk in ten years, whereas individuals who endorsed using reappraisal more frequently showed a 
5.9% decrease in risk. In this study, CVD risk was defined using an algorithm that integrated 
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age, total cholesterol, HDL cholesterol, systolic blood pressure, medication use, smoking, and 
Type II diabetes.  
Studies have also examined associations between emotion regulation strategies and 
activation of specific brain regions. These studies show that use of reappraisal is associated with 
decreased activation of limbic areas (e.g., Drabant et al., 2009; Giuliani, Drabant, & Gross, 2011) 
and increased activation of areas of the prefrontal and temporal cortex that modulate limbic 
activation (Buhle et al., 2014). Conversely, available studies show that use of suppression is 
associated with increased activation in limbic areas such as the amygdala and insular regions 
(e.g., Goldin et al., 2008). As noted previously, these limbic areas have direct projections to other 
brain areas that modulate the actions of the HPA axis and ANS system. Taken together, these 
findings, along with findings showing that reappraisal may be generally more effective in the 
reduction of self-reported negative affect compared to suppression (Aldao, Nolen-Hoeksema, & 
Schweizer, 2010; Webb, Miles, & Sheeran, 2012), suggest that individuals who endorse frequent 
use of emotion suppression may display patterns of autonomic output that have peripheral 
consequences for the development of CVD. In this regard, the majority of available studies find 
that, compared to reappraisal or control conditions, the use of emotion suppression is related to 
increased SNS activity (e.g., Demaree, Schmeichel, et al., 2006; Egloff et al., 2006; Gross & 
Levenson, 1993, 1997; Kunzmann, Kupperbusch, & Levenson, 2005; Roberts, Levenson, & 
Gross, 2008; Robinson & Demaree, 2007). These studies used skin conductance level, finger 
temperature, and pre-ejection period as noninvasive peripheral markers of SNS activity. Though 
limited in number, studies have also examined the association of suppression and reappraisal 
with a common peripheral marker of PsNS activity—heart-rate variability. Here, findings are not 
as consistent, with some studies showing emotion regulation strategies such as reappraisal 
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associate with higher PsNS activity, when compared to emotion suppression (e.g., Denson, 
Grisham, & Moulds, 2011), while other studies finding that both suppression or reappraisal  
associate with higher PsNS activity, compared to control conditions (e.g., Butler, Wilhelm, & 
Gross, 2006).  
  To date, only one study, Lam, Dickerson, Zoccola, and Zaldivar (2009) has examined 
the association between emotion regulation strategies of reappraisal and suppression with 
cortisol levels. They found that university students who endorsed more frequent use of emotion 
suppression showed greater cortisol reactivity to a social-evaluative task, compared to 
individuals who scored low on emotion suppression measures. Interestingly, in this study, they 
also found that individuals who were high on reappraisal showed an exaggerated cortisol 
response to the task.  In sum, the few studies examining associations of cortisol levels and PsNS 
activity with emotion regulation strategies are inconsistent, making it difficult to draw 
conclusions. However, there is sufficient evidence that individuals who frequently employ 
emotional suppression show heightened SNS activation relative to those using reappraisal, which 
may be reflected in changes in the periphery, including increased systemic inflammation.  
So far, only two studies have investigated the association between the emotion regulation 
strategies of reappraisal and suppression and markers of inflammation. In two separate cross-
sectional studies, Appleton et al. (2013, 2014) found that individuals who endorse using emotion 
suppression as a primary emotion regulation strategy showed elevated CRP, when compared to 
individuals who endorse using reappraisal. Therefore, as an extension of this cross-sectional 
association, a second aim of the proposed study is to examine whether emotion regulation 
strategies of suppression and reappraisal relate to systemic inflammation measured prospectively 
across twelve months among mothers of children recently diagnosed with cancer. It is 
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hypothesized that greater use of reappraisal will relate to lower levels of systemic inflammation, 
as indexed by IL-6 levels, at time of diagnosis and a faster decline in inflammation across the 
twelve months follow-up period. Conversely, it is expected that greater use of suppression will 
relate to higher levels of inflammation at time of diagnosis and slower decline in inflammation 
across the twelve months post-diagnosis timeframe.  
1.4 EXPLORATORY AIMS 
As noted previously, a growing literature shows emotion regulation strategy use 
influences self-reported negative affect, which in turn has been shown to relate to inflammation 
levels. These associations raise the possibility that self-reported distress may be a mediator in the 
link between emotion regulation strategy use and systemic inflammation. As such, an 
exploratory aim of the proposed study is to investigate whether, at time of diagnosis, self-
reported distress levels mediate the hypothesized association between emotion regulation 
strategy use and inflammation. This exploratory aim depends on whether we can confirm 
previous findings in the current study and show that a) suppression and reappraisal are related to 
T1 or change in distress levels, and b) distress levels are related to inflammation.  
In addition to examining the main effects of reappraisal and suppression, the possibility 
that reappraisal and suppression are not independent predictors but interact in predicting distress 
and inflammation levels at time of diagnosis will also be explored. Of note, the reason for 
limiting interaction analyses to time of diagnosis and not exploring the possibility that 
reappraisal and suppression may interact to predict change in distress or inflammation is that the 
study is not adequately powered to explore 3-way interaction (i.e., suppression x reappraisal x 





The sample is a representative group of mothers of children under the age of 17 who were 
newly diagnosed with cancer. Participants (N=120) were recruited from the Division of 
Hematology and Oncology, Children’s Hospital of Pittsburgh (CHP) as part of a randomized 
controlled study designed to examine the efficacy of a supportive stress management 
intervention. Approval was obtained from the hematology-oncology treatment team at CHP and 
the IRB institutional review at the University of Pittsburgh. Because of vast differences in course 
and length of treatment, mothers of children with central nervous system cancer or early stage 
lymphoma were excluded. Mothers of children with less than 4 months of life expectancy, as 
determined by primary oncologist, or those with a pervasive developmental disorder were also 
excluded. Inclusion criteria included: (1) 18 years of age or above; (2) being the legal guardian 
of a child who was newly diagnosed with cancer; (3) English fluency; (4) no reported clinical 
history of psychotic or bipolar illness, neurological disorder (stroke, transient ischemic attacks, 
Parkinson’s disease, multiple sclerosis) or chronic disease known to influence immune function, 
including cardiovascular disease, cancer [within the past  2 years], or autoimmune disease; (5) 
not taking medications that might alter responses to questionnaires or indices of immune 
function (including major sedatives or glucocorticoid, anti-inflammatory, anti-retroviral, or 
immunosuppressant medication (6) not pregnant; and (7) not working nightshift.  The last 







With the approval of the hematology-oncology treatment team, potentially eligible 
mothers were approached around 2 weeks after their child’s diagnosis by a research team 
member to explain the study. Mothers who consented to participate were asked to complete 
paper-and-pencil questionnaires at three time points. The initial goal was to obtain data from 
mothers within 2 weeks, 3 months and 6 months from their child’s diagnosis. However, actual 
data collection often deviated from this timeline. Average number of days from diagnosis that 
elapsed for the first, second and third data collection time points were 35.53 (SD =24.70), 204.40 
(SD =58.23), and 382.21 (SD = 65.94). Therefore, data was collected, on average, at 
approximately 1 month (T1), 6 months (T2) and 12 months (T3) from the child’s diagnosis. On 
each occasion, a study staff member met with the mothers in the Pediatric Clinical and 
Translational Research Center (PCTRC) at CHP and gave them individual questionnaire packets. 
Participants were asked to return all questionnaires within 3 weeks either by mail or in person 
during their next appointment in the PCTRC. If questionnaires were not returned within the 
designated period, participants were contacted. During all 3 visits to the PCTRC, mothers were 
also seen by a registered nurse who drew a blood sample (30 ml). At the time of the blood draw 
mothers reported a) no signs of infection or other acute inflammatory condition, and b) not 
having taken antibiotics for the prior 2 weeks or over-the-counter anti-inflammatory medications 
in the past 12 hours. If participants reported/showed symptoms of an infection or other acute 
inflammatory condition, had taken antibiotics in the past 2 weeks, or had taken over-the-counter 
anti-inflammatory medications in the past 12 hours, the appointment was rescheduled. All 3 
assessments were scheduled at the same time of day to control for diurnal variations in systemic 
markers of inflammation.  Participants were financially compensated $25 dollars for completing 
each assessment and a total of $75 for completing all three assessments.   
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2.3 MEASUREMENTS OF COVARIATES 
2.3.1 Health history and demographic information 
Mothers completed questionnaires assessing demographic (e.g., age, race, smoking 
status, body mass index, etc.) and personal history of psychiatric and medical illness. 
2.3.2 Group status  
Following the baseline period, mothers were randomly assigned to a usual care, control 
group or an intervention group. The usual care group received regular support care that is 
provided at the CHP for families of children diagnosed with cancer, which included access to 
clinical social workers. The intervention group received 6 sessions of psychoeducational and 
practical intervention in stress management over the course of 3 months. It is expected that over 
the course of the study these two groups will show differences in variables of interest, including 
distress, and inflammation levels.  
2.3.3 Treatment intensity 
It is most likely that the child’s prognosis or the intensity of the treatment s/he receives 
will influence the distress levels of mothers. As a result, based on the child’s medical/treatment 
record, the treating oncologist provided a treatment intensity rating for each child of participating 
mothers. More specifically, information regarding type of cancer, stage or risk level, whether or 
not current cancer is a relapse, and type of treatment modality (e.g., surgery, chemo, radiation, 
etc.) were used to provide an overall  rating of treatment intensity from 1 (least intensive 
treatment) to 4 (most intensive treatment).  
2.3.4 Social Economic Status (SES) 
Social economic status was evaluated based on education level (4-level category: high 
school diploma or lower, some college, bachelor’s, or graduate degree). SES is an important 
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covariate to assess because of strong evidence of its link with psychological and physical health. 
For example, individuals from lower SES have been shown to experience more depression, 
anxiety, and anger (Gallo & Matthews, 2003; Lorant et al., 2003). They also report more 
negative social experiences and relationships (e.g., Gallo, Smith, & Cox, 2006). Similarly, 
several studies have linked low SES to elevated levels of inflammation (e.g., Friedman & Herd, 
2010; Nazmi & Victora, 2007). Furthermore, more recently, studies have shown that SES may 
also relate to emotion regulation strategy use. For example, higher reappraisal scores have been 
shown to be related to higher educational attainment, while suppression scores were related to 
lower educational attainment and lower childhood SES (e.g., Appleton et al., 2014).   
2.4 MEASUREMENTS OF STUDY VARIABLES 
2.4.1 Emotion Regulation 
The extent to which mothers endorse using reappraisal or suppression emotion regulation 
strategies was evaluated using the Emotion Regulation Questionnaire (ERQ; Gross & John, 
2003). The ERQ is a 10-item self-report questionnaire that consists of two scales corresponding 
to the typical use of two different emotion regulation strategies: cognitive reappraisal (6 items; 
e.g., “when I want to feel less negative emotions, I change the way I’m thinking about the 
situation”) and expressive suppression (4 items; e.g., “I keep my emotions to myself”).  Each 
item on the questionnaire is rated on a Likert scale from 1 (strongly disagree) to 7 (strongly 
agree). The ERQ has demonstrated good internal consistency (Cronbach alpha of .79 for 
reappraisal and .73 for suppression) and a 3-month test-retest reliability of .69 (Gross & John, 
2003). ERQ continued to show adequate internal consistency within this sample. Cronbach alpha 




2.4.2 Measures of psychological outcome 
Three different questionnaires were used to capture symptoms of depression, anxiety, and 
perceived general distress experienced by mothers during the course of the study. 
2.4.2.1 Depression 
Mothers self-report of depressive symptoms were assessed using the 21-item Beck 
Depression Inventory (BDI; Beck et al., 1961). This scale is widely used to assess symptoms of 
depression. This scale has also been shown to be reliable with internal consistency coefficient 
alpha of .81 and test-retest correlations ranging from .6 to .9 in nonpsychiatric populations. 
Concurrent validity has also been demonstrated, with BDI correlating with clinical ratings 
(correlation of .60) and other measures of depressive symptoms (e.g., Hamilton Psychiatric 
Rating Scale for Depression; correlation of .74) (Beck, Steer, & Garbin, 1988).  
2.4.2.2 Anxiety 
The State-Trait Anxiety Inventory (STAI; Spielberger, 1983) is one of the most 
frequently used measures of anxiety. It assesses as separate scales dimensions of “state” and 
“trait” anxiety. Each scale consists of 20 statements that require individuals to rate how they feel 
on a 4-point scale (e.g., calm, upset, etc.). The state measure asked people to describe how they 
feel at a particular moment in time. The trait scale measures a general propensity to experience 
symptoms of anxiety and asks how people generally feel. Internal consistencies coefficients 
ranged from .83 to .92 for the state scale and from .86 to .92 for the trait scale. Test-retest 
reliabilities for the trait scale have shown to be high, ranging from .73 to .86 (Spielberger, 1983). 
2.4.2.3 Perceived Stress  
Levels of perceived stress among mothers was assessed using the 10-item Perceived 
Stress Scale (PSS; Cohen, Kamarck, & Mermelstein, 1983). This scale assesses the degree to 
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which a person appraises current stressors exceed his or her ability to cope. More specifically, 
respondents are asked how often in the last month they experience specific feelings, such as 
“feeling confident about your ability to handle personal problems,” and “difficulties piling up so 
high that you could not overcome them.” This measure has shown strong psychometric 
properties with coefficient alpha reliability ranging from .84 to .86.  
2.4.3 Measures of physiological outcomes 
 Inflammation is the result of a complex and interactive network of systems.  Most human 
studies are limited to quantitative and functional assessments of immune/inflammation 
parameters in peripheral circulation. Quantitative assessment strategies often include measuring 
absolute numbers or relative percentages of specific immune cells and/or their biochemical 
mediators (e.g., cytokines). Functional assessment strategies typically measure susceptibility to 
inflammation, by examining in vitro production of inflammatory mediators by immune cells 
stimulated with endotoxin. In the present study, to assess inflammation, the pro-inflammatory 
cytokine IL-6 was selected. As mentioned previously, IL-6 is a widely used marker of 
inflammation that stimulates the production of CRP, an acute phase protein released from the 
liver that serves as a marker of systemic inflammation and has been reliably associated with 
CVD risk (Libby & Ridker, 1999; Libby, Ridker, & Maseri, 2002).  
2.4.3.1 Circulating levels of inflammation  
Circulating levels of pro-inflammatory cytokines, such as IL-6, provide a relatively stable, 
quantitative measure of systemic levels of inflammation at the time of the blood draw. Of the 
different inflammatory cytokines, IL-6 has a longer half-life and is more reliably detectable using 
high-sensitive assay kits even among asymptomatic individuals. In the proposed study, plasma 
concentrations of IL-6 were analyzed from frozen plasma samples processed in batches in the 
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Behavioral Immunology Laboratory at the University of Pittsburgh (Dr. Marsland, Director). 
Final IL-6 levels were quantified using a high sensitivity enzyme-linked immunosorbent assay 
(ELISA) kit run according to manufacturer’s directions. All samples were run in duplicate. 
Values were accepted if average coefficients of variation (CV) between duplicates were < 20%.  
Average CV for circulating IL-6 were 7.14%, 7.59%, and 7.71% for T1, T2, and T3, 
respectively.  
2.4.3.2 Stimulated levels of inflammation  
In addition to circulating levels of IL-6, the proposed study examined stimulated levels. 
As mentioned, stimulated levels of pro-inflammatory cytokines reflect the functional capacity of 
white blood cells to mount an inflammatory response following endotoxin stimulation (i.e., 
provide a measure of immune competence). This method is believed to capture immune 
responses that are localized in vitro and may not be necessarily reflected in systemic levels.  
Individuals vary in the magnitude of this measure of inflammatory potential, and it is suggested 
that individuals who mount ‘exaggerated’ responses may be at increased risk for inflammatory 
conditions and other illnesses. In the proposed study, IL-6 production was determined by 
stimulating whole blood with lipopolysaccharide (LPS) at a final concentration of 2.5 μg/ml. The 
samples were incubated at 37 degree Celsius with 5% Carbon Dioxide for 24 hours. Following 
incubation, harvested supernatants were frozen at -80 degree Celsius and analyzed in batches. 
Stimulated levels of IL-6 were determined using the same procedure as circulating levels. 




2.5 DATA ANALYSES 
 Statistical analyses were performed using SPSS software package for Windows (SPSS 
Inc., Chicago, IL).   
2.5.1 Preliminary analyses 
Basic growth curve analyses were conducted to determine if there were significant 
differences in individual trajectory of emotion regulation strategy use across the three time 
points. More specifically, the statistical significance of the random effect of time in predicting 
reappraisal and suppression use was tested. A second set of basic growth curve analyses were 
conducted to test whether participants in the control or intervention group (i.e., group status) 
showed significant differences in reappraisal and suppression use across time. Here, emotion 
regulation strategy use of reappraisal and suppression were set as outcome variables and group 
status as a fixed predictor. If a significant estimate for group status in predicting emotion 
regulation strategy was observed or if there were significant differences in emotion regulation 
strategy use across time, then level of reappraisal and suppression was determined using scores 
from the initial point of assessment (i.e., T1).  If there were no significant differences, individual 
use of reappraisal and suppression was determined by averaging scores for the first two time 
points to compensate for missing ERQ data at T1.   
Bivariate correlations showed a high correlation among measures of distress at each of 
the three time points. For instance, at T1, symptoms of depression correlated with both state and 
trait anxiety levels and perceived stress with Pearson r values ranging from .75-.80.  As a result, 
a combined measure of distress was calculated by aggregating scores from the three separate 
measures: symptoms of depression (BDI; Beck et al., 1961) and anxiety (STAI; Spielberger, 
1983), and overall perceived stress (PSS; Cohen, Kamarck, & Mermelstein, 1983). Scores were 
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combined by calculating an overall mean and standard deviation across the three time points for 
each measure.  This mean and standard deviation was then used to obtain a standardized score 
for each individual on each measure at each time point. Subsequently, standardized scores were 
averaged across the different measures of distress to obtain an averaged “distress” score for each 
individual at each time point.   
Of note, actual data collection timeline varied widely among participants. As a 
consequence, instead of a structured “time” variable (i.e., 0, 1, 2), to capture individual time 
point variations, analyses were conducted using an unstructured “time” variable that reflected the 
actual time from diagnosis in months. 
2.5.2 Hypotheses testing 
2.5.2.1 Hypothesis 1  
Multi-level linear growth curve analyses were used to test the first hypothesis. More 
specifically, to determine whether emotion regulation strategy influenced levels of distress at T1 
and over time, the significance of the fixed effects for the variables of reappraisal, suppression, 
and the cross-level time x emotion regulation strategy interaction terms on distress were 
evaluated. In these models, the fixed effects for the main covariates of the study including age, 
race, treatment intensity, group status, and SES (education) were included. Given that this study 
was a part of an intervention study, there is a possibility that there may be a group x time effect 
on outcome variables, including distress. As a result, in all models, the time x group interaction 
variable was included as a covariate.  
2.5.2.2 Hypothesis 2  
To test the second hypothesis (i.e., levels of reappraisal and suppression use predicting 
change in IL-6 levels over time), similar analyses as hypothesis 1 were conducted, with IL-6 as 
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the outcome variable and the addition of BMI as a covariate. Here, we first checked to see if 
there were significant within-person differences in BMI across the three time points. To do this, 
we conducted another basic growth curve analysis and checked the significance of time on BMI. 
If BMI did not significantly change over time, we planned to control for BMI by including it in 
our model as a fixed effect.  If there were, however, significant within-person changes across 
time then we planned to include the time x BMI interaction in the model.   
2.5.2.3 Exploratory hypotheses  
 If we observed support for the first two hypotheses, we planned an exploratory 
examination of whether any associations between emotion regulation strategy and changes in 
inflammation over time were related to distress. Here, we planned to conduct mediational 
analyses using averaged slope estimate for change in distress as a mediating variable. We 
planned to obtain the distress and inflammation slope estimates by saving predicted estimates of 
basic growth curve analyses as separate variables (i.e., after examining the effect of time on 
distress and inflammation, controlling for covariates). Following the creation of these slope 
estimates as separate variables, we proposed using the PROCESS macro for SPSS (Hayes, 2013) 
to test the significance of the mediation.  Of note, if we found that reappraisal and suppression 
were related to initial distress and inflammation, but not significantly related to change in 
distress and inflammation across the follow-up period, we planned in examining the significance 
of initial distress level as a mediator in the association between initial emotion regulation 
strategy use and inflammation.  
In order to test our second exploratory aim (i.e., use of reappraisal and suppression may 
interact in the prediction of initial distress and inflammation), an interaction term was created 
after centering (using Z-scores) and multiplying scores of the reappraisal and suppression 
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variables. Subsequently, multiple regression analyses were conducted including this “reappraisal 
x suppression” interaction term (along with the main effect of reappraisal and suppression) as a 























Participant characteristics are presented in Table 1 for the 120 participants.   
3.1 PRELIMINARY FINDINGS 
Circulating and stimulated levels of IL-6 were log transformed to better approximate a 
normal distribution. All other data were normally distributed. Preliminary correlational analyses 
showed age, SES, and treatment intensity were significantly related to several outcome variables 
(see Table 2), confirming the need to treat them as covariates in all multivariate analyses. For 
example, results showed increasing age tended to relate to endorsing reappraisal tendencies (r = 
.18, p = .06), experiencing less distress around the time of the child’s diagnosis (r = -.17, p = 
.07), and displaying lower levels of circulating IL-6 at T1 (r = -.18, p =.07) and at T3 (r = -.27, p 
= .02). Consistent with previous findings, we also observed that higher education attainment/SES 
related positively to the use of reappraisal (r = .23, p =.01) and negatively to the use of 
suppression (r = -.25, p <.01) at T1. SES was also associated with lower distress levels at T2 and 
T3 (r = -.21, p =.04; r = -.18, p =.10, respectively) and lower T1 levels of circulating (r = -.22, p 
= .02) and stimulated IL-6 (r = -.25, p = .01). Surprisingly, we found that higher child treatment 
intensity related to lower circulating levels of IL-6 at all three time points (T1: r = -.17, p =.07; 
T2: r = -.33, p <.01; T3: r = -.28, p < .01). BMI was included as a fixed effect covariate for all 
analyses involving IL-6 data because it tended to relate positively to circulating IL-6 at all three 
time points (T1: r =. 16, p =.10; T2: r =.18, p= .10; T3: r = .27, p =.01) and to stimulated levels at 
T3 (r = .24, p = .04). Because basic growth analysis showed that BMI did not significantly 
change over time (β10=.031, SE = .960, p = .131), we did not control for a cross-level time x BMI 
interaction during hypotheses testing. Smoking status was not related to any of the outcome 
variables and thus was not included as a control variable in any analysis (see Table 2). 
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Basic growth curve analyses confirmed the time x emotion regulation strategy effect was 
not significant (Reappraisal: β10 = .052, SE= .075, p = .490; Suppression: β10= -.063, SE=.054, p 
=.250), suggesting that the use of reappraisal or suppression did not change over time. There was 
also no significant difference in reappraisal and suppression use across time between the 
intervention and control group (Reappraisal: β10 = .285, SE =.960, p =.767; Suppression: β10= -
.147, SE = .844, p =.083). Therefore, average ERQ scores across the first two time points were 
used in the primary analyses. As expected, initial reappraisal and suppression use were not 
significantly correlated with each other (r = -.072, p = .457), highlighting that the two variables 
are largely independent.  Therefore, we were also able to explore whether reappraisal and 
suppression interact in the prediction of distress and inflammation (second exploratory aim).    
3.2 TESTS OF PRIMARY HYPOTHESES 
3.2.1 Emotion regulation strategy and distress 
There was a significant decrease in distress across the three time points with a mean rate 
of decline per month being β10= -.044 (SE = .007, p <.01; Figure 1). We hypothesized that 
emotion regulation strategy use would relate to the initial levels of distress as well as rate of 
change in distress level. More specifically, we expected reappraisal to relate to lower initial 
distress and a faster decrease in distress over time. In contrast, we expected suppression to relate 
to higher initial distress and a slower decrease in distress over time. Findings partially supported 
our hypothesis. While reappraisal related to lower level of distress at time of diagnosis (β01= -
.254, SE = .087, p = .004), it did not relate significantly to rate of change in distress (β11=.002, 
SE=.007, p = .792). Similarly, we found that initial suppression related to higher level of distress 
at time of diagnosis (β01= .354, SE = .086, p < .01), but it did not predict rate of change in 
distress level (β11= -.003, SE=.007, p = .628; see Table 4).  
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3.2.2 Emotion regulation strategy and inflammation 
Both circulating and stimulated IL-6 levels significantly increased over time, at a rate of 
β10= .039 (SE = .006, p <.01; Figure 2) and β10= .035 (SE =.006, p <.01; Figure 3) per month, 
respectively. We hypothesized that reappraisal would relate to lower initial inflammation and a 
faster decline in inflammation levels across the twelve months, while suppression would relate to 
higher initial inflammation and a slower decline in inflammation across the follow-up period. In 
general, findings did not support our hypothesis (see Table 5 and 6). Reappraisal did not relate to 
initial circulating or stimulated levels of IL-6 (Circulating IL-6: β01= .063, SE =.087, p =.468; 
Stimulated IL-6: β01=.028, SE =.089, p =.749). Reappraisal also did not significantly relate to 
rate of change in circulating or stimulated IL-6 levels over time (Circulating IL-6: β11= -.002, SE 
=.006, p =.700; Stimulated IL-6: β11= -.004, SE =.005, p =.414).  We also did not observe a 
significant association between suppression and initial circulating or stimulated IL-6 (Circulating 
IL-6: β01= .028, SE =.089, p =.749; Stimulated IL-6: β01=.002, SE =.069, p =.978). However, 
suppression did significantly predict rate of change in stimulated IL-6 levels (β11 = -.016, 
SE=.006, p =.012). As illustrated in Figure 4, contrary to expectations, higher suppression scores 
related to slower increases in levels of IL-6.  A similar but weaker pattern of association was 
observed with rate of change in circulating IL-6 levels (β11 = -.011, SE=.007, p =.118).  
3.2.3 Exploratory aims  
 One of the exploratory aims of the current study was to examine the possibility that self-
reported distress mediates the hypothesized relationship between emotion regulation strategy use 
and change in inflammation. As previously indicated, while we did find suppression significantly 
predicted rate of change in stimulated IL-6 levels, results did not show that reappraisal or 
suppression significantly related to rate of change in distress levels. While current accepted 
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guidelines for conducting mediational analyses no longer require a significant association 
between the predictor (emotional regulation strategy) and outcome variable (inflammation), 
significant associations between the predictor and mediator (distress) and  between mediator and 
outcome variables are still considered by most an essential precondition for mediational analysis 
(Hayes, 2013, p.88-89). For this reason, we were unable to conduct mediational analyses using 
slope estimates for change in distress as the mediating variable.  Consequently, we proceeded to 
examine cross-sectional associations among emotion regulation strategy use, inflammation and 
distress only at T1. For this purpose, we conducted multiple regression analyses. Controlling for 
covariates, initial reappraisal was negatively related to distress (β = -.233, p = .015), while 
suppression was positively related with distress (β = .335, p = .001). Neither reappraisal nor 
suppression were significantly related to circulating or stimulated IL-6 at T1 (see Table 7). 
Furthermore, distress levels at time of diagnosis were not significantly associated with 
circulating (β = .048, p =.492) or stimulated IL-6 levels (β = .021, p =.836). For this reason, we 
were also unable to conduct mediational analyses using distress at T1 as a mediator of the 
association between emotion regulation strategy use and inflammation at T1.  
 Our second exploratory aim was to investigate the possibility that reappraisal and 
suppression interact to predict outcome variables. Here, we did not find significant associations 







Consistent with Vrijmoet-Wiersma et al. (2008)’s review, the present study observed 
mothers of children diagnosed with cancer report high levels of negative emotions, such as 
symptoms of depression and anxiety, around the time of their child’s diagnosis. For example, in 
the current study, average BDI score at T1 was 18.42 (SD = 11.69), which is classified as within 
the mildly depressed range (see Beck, Steer, & Carbin, 1988). By the end of the study 
(approximately 12 months post-diagnosis), on average, mothers showed a significant decrease in 
depressive symptoms and other negative affect (as measured by our combined distress measure). 
However, mean levels remained elevated when compared with normative levels. Average BDI at 
T3 was 13.63 (SD = 12.14) which falls just above the normative cutoff for possible clinical 
depression, which is 13 (see Beck, Steer, & Carbin, 1988). There was also considerable inter-
individual variability in trajectories of distress.  One important goal of this study was to examine 
the possibility that individual differences in use of emotion regulation strategies would influence 
emotional reactions among mothers of children newly diagnosed with cancer contributing to 
variability in levels of distress over time. Theory (i.e., Gross’s process model of emotion 
regulation) and a number of studies highlight the emotional benefit of using reappraisal 
strategies when compared to suppression strategies. For example, individuals who employ 
reappraisal strategies show a less negative emotional response during acutely stressful situations 
than those who report using suppression strategies (see review by Webb, Miles, & Sheeran, 
2012). Furthermore, growing evidence associates use of reappraisal strategies with better mental 
health (see review by Aldao, Nolen-Hoeksema, & Schweizer, 2010). Based on this, we 
anticipated that mothers who reported using reappraisal to manage emotions related to having a 
child diagnosed would show lower levels of distress at T1 and faster declines in distress across 
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time. Conversely, we expected that mothers who used suppression would show higher initial 
levels of distress and a slower rate of decline across the twelve months follow-up.  Cross-
sectional associations were consistent with our hypotheses, with reappraisal predicting lower 
distress levels around the time of diagnosis while suppression related to higher reports of 
distress. However, longitudinal analyses showed no associations of reappraisal or suppression 
with rate of change in distress.  It is unclear why reappraisal and suppression related robustly to 
T1 distress levels but not to rate of change in distress over time. It is impossible to determine the 
direction of effects in cross-sectional associations, raising the possibility that distress at T1 
influences the nature of the emotion regulation strategy that was used. More specifically, it is 
possible that at the peak of emotional intensity (i.e., T1), individuals that are highly distressed 
may tend to engage in suppression while those that are less distressed may be more likely to 
engage in reappraisal, contributing to a significant association between emotion regulation use 
and distress. However, as individuals adjust to the stressor and distress decreases, as it does in 
this study, intensity of distress may be less relevant to emotion regulation strategy use, 
minimizing the strength of association between emotion regulation strategy use and distress 
levels over time. In support of this possibility, studies have shown that individuals tend to engage 
in reappraisal regulatory strategy when confronted with a low-emotional intensity stressor 
compared to a high-emotional intensity situation. In the latter, the preference tended to be for 
individuals to engage in disengagement, distraction or other avoidant strategies (e.g., Sheppes, 
Scheibe, Suri, & Gross, 2011).  
Another possible explanation for not finding an association of emotion regulation 
strategy and change in distress over time may relate to type and chronicity of the stressor. 
Drawing parallels from the coping literature, coping strategies are often categorized as problem-
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focused strategies (e.g., problem-solving, engaging in reappraisal, etc.) or emotion-focused 
strategies (e.g., emotion avoidance, engaging in distraction, etc.). A number of studies suggest 
that the controllability of a stressor may determine the relative usefulness or adaptiveness of 
using problem-solving versus emotion-focused strategies. For example, Park, Armeli, and 
Tennen (2004) asked undergraduates to fill daily self-report measures of coping strategies, mood 
and controllability of a stressor for one month. They found that the use of problem-focused 
coping strategies was related to more positive mood when stressors were deemed controllable by 
participants. However, this association was not present when stressors were classified as 
uncontrollable. In the present study, participants are mothers who are exposed to a unique 
prolonged stressor most likely making the association between use of emotion regulation 
strategies and emotional adjustment even more complex. For instance, around the time of 
diagnosis, mothers are confronted with a need to juggle several tasks and responsibilities with 
time and financial constraints, which most likely challenges their problem-solving abilities and 
their ability to express their needs, emotional or otherwise, to others. At this time, mothers who 
endorse high suppression use may be at a disadvantage. However, as time passes and mothers 
adjust to new routines and schedules, suppression use may be less relevant. In support of this 
possibility, in exploratory analyses, we found that mothers who endorsed higher suppression use 
also reported receiving lower social support at T1 (β = -.39, SE =.08, p <.01), as measured by the 
Interpersonal Support Evaluation List (ISEL; Cohen et al., 1985)—a questionnaire that assesses 
both perceived emotional and tangible support received from others. However, suppression did 
not predict change in social support. On the other hand, reappraisal was not related to social 
support at T1 but tended to relate to greater increases over time in self-reported social support (β 
= .01, SE =.005, p = .08). Since we did not find that suppression and reappraisal were correlated 
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to each other, it is entirely possible that there are individual differences in frequent usage of one 
strategy over another, with some individuals being low or high in one strategy or on both 
strategies—potentially influencing different patterns of change in distress levels over time. 
Unfortunately, the present study was not adequately powered to explore how reappraisal and 
suppression interact to predict rate of change in distress. Furthermore, while reappraisal and 
suppression did not interact significantly to predict T1 distress, the effect size obtained (β = -
.147, p =.110) suggests the possibility that significance may be achieved in a larger sample.   
Given the strong literature linking negative emotional states such as anxiety and 
depression and inflammation levels (e.g., Kiecolt-Glaser et al., 2002; Sergestrom & Miller, 2004; 
Irwin & Miller, 2007), we expected that distress and inflammation would be related across time 
in the current study.  In our preliminary analyses, we found that while distress levels decreased 
over time, inflammation, as measured by circulating and stimulated levels of IL-6, increased 
significantly over the course of the study. While unexpected, the finding that inflammation 
increased as more time elapsed from diagnosis is not unprecedented. While there is a consistent 
literature showing an association between acute/brief stressors and elevated inflammation, 
findings are less consistent and suggest a more complex association between type of chronic 
stressors and the immune system (Sergerstrom & Miller, 2004). Furthermore, there is an existing 
literature examining inflammation levels among caregivers of individuals with chronic 
illnesses—a similar stress paradigm to the present study. Here, studies have shown that 
caregivers tend to exhibit increasing levels of inflammation over time, including circulating IL-6, 
CRP and TNF-α (Kiecolt-Glaser et al., 2003; von Kӓnel et al., 2012),  which may place them at 




Furthermore, while in the present sample we found that mothers exhibited an average 
decrease in distress, as mentioned previously, studies of this population suggest that a subset of 
these mothers report persistently elevated or increasing levels of distress for a period of up to 
five years (Vrijmoet-Wiersma et al., 2008). It is possible that this subgroup with elevated distress 
contributes disproportionately to increases in inflammation over time. In support of this 
possibility, other works from our lab, using the same sample of mothers, have revealed that 
around 35% of mothers show an increase or fail to show a decrease in distress levels over time 
(note: distress in these studies was measured monthly using PSS only). In addition, this subgroup 
of mothers showed significant increases in circulating (β10=.036, SE = .009, p <.001) and 
stimulated levels of IL-6 (β10 =.033, SE= .014, p=.026) across the follow-up period, after 
controlling for relevant covariates. In contrast, mothers who showed a decrease in distress over 
time showed no significant change in circulating IL-6 (β10 =.018, SE = .016, p=.296) and the 
increase in stimulated IL-6 was weaker (β10 =.027, SE = .015, p =.072).  
 There may also be a methodological explanation for the lack of significant association 
between distress and inflammation over time. In the current study, distress was measured using 
questionnaires asking participants to recall experienced negative emotions. Inflammation, on the 
other hand, was assessed using an objective biological marker. It is possible that, as more time 
elapsed, mothers psychologically habituated to the increased demands of having a child 
diagnosed with cancer and may have appraised their situation as less stressful. However, these 
taxing demands continue to result in physiological consequences. Therefore, it is possible that 
inflammation levels may be capturing the accumulated effect of the chronic stressor, which self-
reported, time-limited measures might not fully capture. This idea of chronic stress evoking 
potentially harmful changes in physiology due to repeated and/or prolonged stressors has 
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garnered increasing attention among health researchers within the context of the theory of 
allostatic load (McEwen & Stellar, 1993).  It is suggested that prolonged activation of brain-to-
peripheral stress systems (i.e., sympathetic-adrenal- medullary (SAM) axis and the HPA axis) 
leads to disruption of feedback regulating these systems, which results in dysregulation of 
peripheral physiology, including elevations in systemic inflammation that contribute to disease 
risk (Juster, McEwin, & Lupien, 2010). In other words, it is possible that self-reported, 
retrospective assessment of psychosocial stress may be imprecise and thus underestimate the 
relationship between distress and inflammation. 
Another important goal of the present study was to extend the cross-sectional findings of 
Appleton and colleagues (2013, 2014) to a longitudinal examination of associations between 
emotional strategy use and inflammation.  More specifically, amending our original hypothesis 
to incorporate the fact that inflammation increased over time in our sample, we expected that 
individuals who tend to engage in reappraisal would show lower initial levels and slower 
increases in both stimulated and circulating IL-6 over time compared to those who engage in 
suppression. Our findings did not support this relationship.  We did not see a cross-sectional 
relationship between emotion regulation strategy use and IL-6 levels at time of diagnosis. 
Longitudinally, the only significant findings showed that individuals who endorsed greater initial 
use of suppression showed slower increases in inflammation levels (note:  the finding with 
circulating IL-6 was a trend and not statistically significant), which is contrary to our predictions. 
One explanation for our largely null findings could be, as previously mentioned, the nature of the 
stressor. Indeed, given the enormity of the threat and the lack of ability to control the situation, it 
is possible that emotion suppression is adaptive in the early months following diagnosis.  
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We also saw that strength of association between suppression and slower increases in IL-
6 was different between circulating and stimulating levels.  Inconsistent findings between 
circulating and stimulated levels are not unusual in the literature. For example, in their 
metaanalytic review of acute laboratory stressors and changes in IL-6, Steptoe, Hamer, and 
Chida (2007), found a modest overall effect for circulating levels of IL-6 with significant 
increases in IL-6 following acute stressors but negligible/nonsignificant effects for stimulated IL-
6.  This inconsistency is primarily due to the fact that circulating and stimulated levels assess 
different aspects of immunity. As mentioned earlier, stimulated levels (i.e.., in vitro assays) 
provide information about the functional ability of specific immune cells. However, to maximize 
accuracy of quantification, these cells are removed from the host and, as such, do not reflect an 
accurate estimate of systemic levels of inflammation. Furthermore, stimulated methods assess 
cytokine production (in this case, IL-6) by white blood cells alone. On the other hand, circulating 
levels (i.e., in vivo assays) provide an integrated assessment of IL-6 released systemically from a 
wide range of sources that include smooth muscle cells and adipocytes as well as immune cells. 
While still debated, generally it is thought that increased production of pro-inflammatory 
mediators in response to acute stress is adaptive, preparing the body for defense against external 
or internal threats (Vedhara, Fox, and Wang, 1999). For instance, among mothers of children 
diagnosed with cancer becoming ill due to an infection would hinder their ability to take care of 
their child and the family as a whole. Therefore, in this regard, our finding that suppression 
related to slower increases in IL-6 among these mothers may be interpreted as a less adaptive 
immune response. In contrast to health-protective effects of increased inflammatory responses in 
the context of acute stress, it is proposed that chronic elevations of systemic inflammation no 
longer serve an adaptive function and may be detrimental to health. In other words, while 
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elevated levels of inflammation may be protective in the short-term (e.g., decreasing risk for 
infection, improving recovery from injury, etc.), in the long term, they may place individuals at 
risk for inflammation-mediated diseases, such as CVD. Following this viewpoint, suppression 
relating to slower increases in IL-6 indicates that it may be a protective factor.  
4.1 LIMITATIONS 
 The proposed study has limitations that may provide several directions for future studies. 
One limitation of the study is both emotion regulation strategy use and distress were evaluated 
using self-reported/subjective measures. As a result, it is possible that some significant 
associations reflect common method biases and/or the contribution of other factors such as social 
desirability or dispositional negative affect that systematically impact how individuals respond 
(Brett et al., 1990; Crowne & Marlowe, 1960; Podsakoff, P., MacKenzie, Jeong-Yeong, & 
Podsakoff, 2003; Watson & Clark, 1984). Second, and a related point, the current study did not 
control for potential personality confounds. It has been suggested that certain personality traits 
may play a role in emotion regulation use and, as a result, in differences in physiological 
responses to a stressor; especially among samples that are stressed or samples that are asked to 
report on dispositional rather than situation-specific factors (Conner-smith & Flachsbart, 2007), 
which is the case in this study.  In a meta-analytic review, Conner-Smith and Flachsbart (2007) 
concluded that extraversion and conscientiousness predicted engaging in problem-solving and 
cognitive reappraisal coping strategies. Neuroticism, on the other hand, associated with strategies 
such as wishful thinking, withdrawal, and emotion-focused strategies. It has also been proposed, 
but few studies have concretely shown, that physiological and/or health consequences of emotion 
regulation may be moderated by personality (Sergestrom, 2000).  
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One explanation provided for the links among personality, emotion regulation and 
physiology is that people who are high in certain traits, such as neuroticism, may expand more 
effort in regulating their emotions (Tobin et al., 2000), resulting in higher physiological arousal 
to stressors. Others suggest that the physiological consequences of a given emotion regulation 
strategy may depend on the extent of a mismatch between personality-driven emotion regulation 
strategy preference and actual behavior. In other words, it is possible that individuals with certain 
personality traits may find suppressing the expression of emotions more aversive and, depending 
on the stressor, may experience this mismatch leading to higher physiological reactivity or 
slower recovery from the stressor (Engebretson, Matthews, and Scheier, 1989; Gračanin, 
Kardum, and Hudek-Knežević, 2013). Thus, for the purposes of the present study, we cannot 
exclude the possibility that some of the associations may be explained by a third confounding 
personality factor.  
In addition to the methodological shortcomings of the present study, there are important 
theoretical limitations of this area of study that may further explain some of our null and 
unexpected findings and provide additional avenues for future research. To date, the focus of 
studies has been on highlighting potential negative health consequences of emotion suppression 
or the benefits of using reappraisal strategies. However, more recently researchers have 
suggested that individual differences in flexibility in emotion regulation strategy may be more 
relevant to health than the use of a given strategy (Rozanski, Blumenthal, Davidson, Saab, & 
Kubzansky, 2005). Recent reviews (Aldoa, 2013; Bonanno & Burton, 2013), however, highlight 
a lack of consistency in conceptualizing and operationally defining “emotion regulation 
flexibility”. Although this research is in its infancy, it is suggested that engaging in suppression 
may be adaptive in some situations. In support of this possibility, a growing number of studies 
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(e.g., Bonanno et al., 2004; Westphal, Seivert, & Bonanno, 2010) show that the ability to flexibly 
alternate facial expressions from suppressing to expressing emotions predicted better 
psychological outcomes. This finding is relevant for the interpretation of our results because 
items of the expressive suppression subscale of the ERQ that are used in the current study 
revolve around external expression of emotions.  Furthermore, mothers of children diagnosed 
with cancer address a range of challenges across the first year following their child’s diagnosis, 
including helping their child deal with chemotherapy and the ups-and-downs of potential 
remission or relapse. It is possible that while emotion regulation strategy use is conceptualized as 
a trait-like characteristic and we did not find a significant average change in emotion regulation 
strategy use over time, there may be a subset of mothers who show changes in reappraisal and/or 
suppression use to meet their environmental demands. To test this possibility, we visually 
examined change over time trajectories for reappraisal and suppression for each individual 
(illustrated in Figure 5). We observed that approximately 25% of participants reported increased 
reappraisal use over the three time points, while 18% showed decreased use. In regards to 
suppression, 23% endorsed increasing suppression tendencies while 32% showed decreasing 
levels. While beyond the scope of the present study, individual differences in patterns of emotion 
regulation use may relate to distress and inflammation levels in important ways that inform our 
understanding of how emotional regulation strategy use relates to health outcomes. 
Unfortunately, studies that have examined the long-term physical health benefits of flexibility in 
emotion regulation are limited. However, it is plausible that individuals who endorse more rigid 
use of one strategy, regardless of that strategy, may experience long-term health consequences, 
including CVD. For instance, our findings show that suppression related to greater self-reported 
distress, but not inflammation, at T1. In contrast, suppression did not relate to change in distress 
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over time, but predicted slower increases in IL-6. These results underline the complexity of 
relationships between the use of suppression and health factors. 
Another limitation of this literature is that studies exploring the physiological 
consequences of suppression or reappraisal do not differentiate positive and negative emotional 
expressiveness. The lack of investigation in this area raises a few questions. For example, do 
individuals who endorse frequent expressive suppression inhibit the display of negative and 
positive emotions equally? Are there differential physiological and long-term CVD 
consequences between suppressing negative and/or positive emotions? It has been argued that 
when experiencing negative affect, people do not typically show purely negative emotions, but 
rather they tend to display a blend of negative, neutral, and even positive expressions (Davidson 
et al., 1994). However, studies that have examined the positive health correlates of displaying or 
suppressing positive emotions are limited. One of the few studies in this area, Davidson, 
Mostofsky and Whang (2010) measured positivity displayed on the faces of almost 2000 
participants during a structured interview. They found that individuals who displayed higher 
levels of positive affect were at 22% reduced risk of developing heart disease over a 10-year 
period, after controlling for both major coronary risk factors and measures of negative affect. 
While this study used observational measurement, future studies can build on this finding by 
evaluating the extent that individuals report differential positive and negative emotion 
suppressive behaviors and relate it to health outcomes.  
Lastly, the current study and indeed the bulk of existing studies on expressive 
suppression (or reappraisal) have primarily focused on the regulation of negative affect 
experience. The few available studies that examined the association between the use of emotion 
suppression and positive emotions have shown that emotion suppression is related to decreases 
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in self-reported positive affect to positive and negative stimuli (e.g., Gross & Levenson, 1997). A 
growing literature highlights an association between positive affect and health outcomes, 
including CVD (e.g., Pressman & Cohen, 2005). Furthermore, it has been proposed that 
individuals who experience more positive emotions throughout a stressful process, regardless of 
the presence of negative emotions, may have different physiological health outcome trajectories 
(Pressman & Cohen, 2005). For instance, studies have shown that positive emotions facilitate 
cardiovascular recovery following a stressor due to decreases in SNS activity (e.g., Fredrickson 
& Levenson, 1998; Fredrickson et al., 2000).  Others have suggested positive emotions may 
relate to increases in PsNS activity (e.g., McCraty et al., 1995). As noted earlier, the autonomic 
nervous system plays a central role in modulating the inflammatory process. SNS activity 
induced beta-adrenergic receptor stimulation of immune cells (macrophages) results in increased 
production and release of pro-inflammatory cytokines while increased PsNS activity and the 
release of acetylcholine binding to immune cells downregulates pro-inflammatory gene 
expression. Taken together, it is conceivable that individual differences in expressivity and 
experience of negative and positive emotions may have distinct neurobiological effects on 
inflammation that can in turn inform CVD risk, which the extant literature has yet to fully 
investigate.  
4.2 CONCLUSIONS AND POTENTIAL IMPLICATIONS OF THE PRESENT STUDY 
A childhood cancer diagnosis is highly distressing to parents and disruptive to the 
functioning of the entire family. This distressing event may be particularly impactful for mothers 
who, in addition to dealing with the potential loss of their child, often carry most of the day-to-
day added burdens of caring for a chronically ill child (Long & Marsland, 2011). As a 
consequence, this group may be particularly at risk for impaired psychological and physical 
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health outcomes, which may in turn further negatively affect the child and the family as a whole 
(Cousino & Hazen, 2013; Barakat et al., 2007). It is understood that emotion regulation, 
including the ability to display appropriate affect, is an emblem of mental health, with several 
psychiatric disorders characterized by disruptions in these abilities. A review by Kennedy-Moore 
and Watson (2001) identified several clinical benefits of expressing negative emotions, including 
reducing the intensity of those emotions, improving likelihood of developing insight about one’s 
ability, and facilitating social support; all three factors would lower distress and alleviate 
suffering. The present study shows that mothers who engage in reappraisal reported lower levels 
of distress around the time of their child’s diagnosis. Conversely, those who engaged in 
suppression reported higher levels of distress. Therefore, it is possible that certain mothers may 
benefit from intervention focused on modifying emotion regulation abilities. In this regard, 
acceptance/mindfulness (e.g., Robins et al., 2012), expressive writing (e.g., Niles et al., 2014), 
and cognitive-behavioral skills training (e.g., Berking et al., 2008) have all been shown to be 
effective in modifying and improving emotion regulation abilities.  Equally important, however, 
the findings from this study highlight the need for further prospective examinations of whether 
emotion regulation strategy use, as measured by the ERQ, influence emotional and physiological 
adaptation to chronic stress—an important step to back the claims of health protective or risk 
effects of individual differences in emotion regulation strategy use that is purported by the 









TABLES AND FIGURES 
Table 1. Participant characteristics 
Characteristic      Total Sample (n =120) 
Age (mean in years)     38.37 (SD =7.87) 
Group status (control)     61 (50.8%) 
Race (white)      102 (86%) 
BMI (mean in kg/m2)     28.97 (SD =7.60) 
Smoking status (smokers)    48 (36.9%) 
Relation to child 
 Biological     114 (95%) 
 Foster Parent     3 (2.5 %) 
 Guardian Parent    1 (~1%)  
 Other      2 (~2%) 
Marital Status  
 Married     71 (59.7%) 
 Never Married     31 (26.1%) 
 Remarried     7 (5.9%) 
 Widowed     6 (5%) 
 Separated     2 (1.7%) 
 Divorced     2 (1.7%) 
SES/Educational Attainment 
 High school diploma or less   30 (25.2%) 
 Some college     59 (49.6%) 
 Bachelor’s degree    18 (15.1%) 
 Graduate degree    12 (10.1%)  
Treatment Intensity received by child* 
 Least intensive    0 (0%) 
Moderately intensive    34 (28.6%) 
Very intensive     67 (56.3%) 
Most intensive    18 (15.1%) 
Note. SES =socioeconomic status. BMI=Body Mass Index. Marital status and BMI that are reported were 










Table 2. Summary of bivariate correlations between measured covariates (age, group status, 
BMI, race, SES, smoking status, marital status and treatment intensity) and variables of interest 
(T1 reappraisal, T1 suppression, distress, circulating and stimulated IL-6)  
 
             Measure       1    2    3    4   5   6   7    
1. Age       _ -.21* .29* .06 .11 .20* .16^ 
2. Race      _   _       -.18*    -.07 -.05 -.06 .12 
3. SES       _   _  _ .00 -.12  .04 .02 
4. Group      _   _  _  _  .08 -.17^ .02 
5. Smoking status     _   _  _  _   _ -.15 .04 
6. BMI       _   _  _  _   _   _ -.14 
7. Treat_Int       _   _  _  _   _   _  _ 
T1 reappraisal   .18^ .01 .23* .01 -.04 .00 .09 
T1 suppression  -.12 -.02 -.25* -.17^ .13 -.02 -.06 
Distress 
  @T1   -.17^ .05 -.07 -.07 -.08 -.00 -.00 
  @T2   -.16 -.10 -.21* -.19^ .11 .03  -.01 
  @T3   -.05 -.08 -.18^ -.15 .01 .00  -.08 
Ln_Circ_IL-6 
  @T1   -.18^ .02 -.22* -.11 .08 .16^ -.17^ 
  @T2   -.14 -.01 -.12 -.03 .00 .18^ -.33* 
  @T3   -.27* -.02 -.18 -.02 .03 .27* -.28* 
Ln_Stim_ IL-6 
  @T1   -.19^ .12 -.25* -.03 -.04 .07 -.06 
  @T2   .01 .03  .01  .01 .11 .11 -.12 
  @T3   -.14 .15 -.09  .03 -.02 .24* .00 
Note. Significance indicators: ^ = < .10, * = ≤ .05 Mother’s relation to child was not examined as a 
covariate because of limited variability with 95% of mothers reporting child undergoing treatment is their 
biological child. Due to the large percentage (86%) of sample being white, race was recoded as 0 = white, 
1 = non-white. SES = socioeconomic status. BMI = body mass index. Smoking status coding: 0 = non-
smoker, 1 = smoker. T1 = initial assessment (~1 month of diagnosis). T2 = second assessment (~ 6 
months post- diagnosis). T3 = third assessment (~ 12 months post-diagnosis). Treat_Int = treatment 
intensity. Group = Group status (1=control, 2=intervention). Circ_ = circulating. Stim_ =Stimulated. Ln= 






Table 3. Summary of intercorrelations, means, and standard deviations for variables of interest (T1 reappraisal, T1 suppression, 
distress, circulating and stimulated IL-6) 
     
                       T1     T2                   T3 
   ___________________________       _____________           ____________ 
  
Measures   1  2   3    4    5  3  4   5  3 4 5         M (SD) 
 
           
T1 
1. Reappraisal  --       -.07      -.25* -.04 -.04          -.30**     .13      -.07          -.31**       .02       -.08    28.23 (5.28) 
2. Suppression  -- --        .34**  .10  .06           .38**      .05     -.12           .37** -.03 -.17    12.74 (1.93) 
3. Distress     -- -- --  .09  .07           .74** .04       .05             .62** .10  .06        .24 (1.02) 
4. Ln_Circ_IL-6 -- -- --  -- .46**           .12 .62** .20^               .15 .68**  .28*              .06 (.91) 
5. Ln_Stim_IL-6 -- -- --  --    --           .14 .26*      .64**           .27* .21^ .44**        4.64 (.67) 
T2 
3. Distress     -- -- --  --    --  -- .10 .06           .80** .08 .09       -.13 (1.12) 
4. Ln_Circ_IL-6 -- -- --  --    --  --   -- .46**           -.00 .85** .48**          .24 (.78) 
5. Ln_Stim_IL-6 -- -- --  --    --  --   --   --            .05 .26* .66**        4.89 (.60) 
T3 
3. Distress     --. -- --  --    --  --   --   --   -- .00 .01         -.24 (.84) 
4. Ln_Circ_IL-6 -- -- --  --    --  --   --   --   --   -- .44**          .59 (.78) 
5. Ln_Stim_IL-6 -- -- --  --    --  --   --   --   --   --   --        5.00 (.60) 
    
Note. Significance indicators: ^ = < .10, * = ≤ .05, ** = ≤ .01. T1 = initial assessment (~1 month of diagnosis). T2 = second assessment (~ 6 months 




Table 4. Fixed effects estimates for models predicting Distress 
 
 
Parameter          Model 1                Model 2     Model 3 
 
Intercept         .250** (.094)    .173* (.086)     .264 (.550) 
MonthsSinceDX       -.044** (.007)  -.043** (.007)   -.048* (.024) 
______________________________________________________________________________ 
Reappraisal       -.254** (.087)   -.247** (.092)  
Suppression        .354** (.087)    .347** (.092) 
MonthsSinceDX*Reappraisal       .002 (.006)     . 001 (.007) 
MonthsSinceDX*Suppression      -.003 (.007)     -.003 (.007) 
______________________________________________________________________________ 
Age            -.001 (.011) 
Race            -.140 (.249) 
SES            -.001 (.095) 
TreatIntensity            .047 (.125) 
Group            -.091 (.181) 
Group*MonthsSinceDX          .003 (.015) 
 
Note. Standard errors are in parentheses. Significance indicators: ^ = < .10, * = ≤ .05, ** = ≤ .01. Model 
1: Basic growth curve; Model 2: Uncontrolled model; Model 3: Controlled model. MonthsSinceDX = 
continuous time variable measures the number of months that elapsed since diagnosis. TreatIntensity = 


























Table 5. Fixed effects estimates for models predicting circulating IL-6 
 
 
Parameter          Model 1                  Model 2     Model 3 
 
Intercept          .005 (.083)   -.006 (.086)          1.099^ (.635) 
MonthsSinceDX       .039** (.006)  .041** (.006)  .033 (.022) 
______________________________________________________________________________ 
Reappraisal        -.007 (.090)  .063 (.087)  
Suppression          .108 (.089)  .028 (.089) 
MonthsSinceDX*Reappraisal     -.000 (.006)           -. 002 (.006) 
MonthsSinceDX*Suppression      -.010(.006)            -.011 (.007) 
______________________________________________________________________________ 
Age                    -.018^ (.010) 
Race                     -.046 (.232) 
SES                    -.154^ (.092) 
BMI          .019^ (.010) 
TreatIntensity                   -.210^ (.121) 
Group          -.122 (.173) 
Group*MonthsSinceDX        .004 (.013) 
 
Note. Standard errors are in parentheses. Significance indicators: ^ = < .10, * = ≤ .05, ** = ≤ .01. Model 
1: Basic growth curve; Model 2: Uncontrolled model; Model 3: Controlled model. MonthsSinceDX = 
continuous time variable measures the number of months that elapsed since diagnosis. TreatIntensity = 























Table 6. Fixed effects estimates for models predicting stimulated IL-6 
 
 
Parameter          Model 1                   Model 2         Model 3 
 
Intercept   4.616** (.061)    .4.612** (.065)    4.938** (.505) 
MonthsSinceDX    .035** (.006)     .034** (.006)       .044* (.020) 
______________________________________________________________________________ 
Reappraisal          -.018 (.067)        .025 (.069)  
Suppression            .045 (.066)        .002 (.064) 
MonthsSinceDX*Reappraisal       -.004 (.006)       -.004 (.005) 
MonthsSinceDX*Suppression      -.014*(.006)     -.016* (.006) 
______________________________________________________________________________ 
Age               -.007 (.008) 
Race                .086 (.186) 
SES               -.107 (.073) 
BMI                .007 (.007) 
TreatIntensity              -.061 (.096) 
Group                .005 (.137) 
Group*MonthsSinceDX            -.007 (.013) 
 
Note. Standard errors are in parentheses. Significance indicators: ^ = < .10, * = ≤ .05, ** = ≤ .01. Model 
1: Basic growth curve; Model 2: Uncontrolled model; Model 3: Controlled model. MonthsSinceDX = 
continuous time variable measures the number of months that elapsed since diagnosis. TreatIntensity = 

























Table 7. Hierarchical Multiple Regression Analyses predicting distress and inflammation at time 
of diagnosis from emotion regulation strategy use 
 
                                              Distress                Ln_Circ_IL-6      Ln_Stim_IL_6 
_____________            _____________             _____________ 
Predictor      ∆R2          β               ∆R2              β                  ∆R2             β 
Step 1    .019            .138*         .075 
Covariates†   
Step 2    .161**     .002                  .002 
Initial Reappraisal      -.233*                .042   .040 
Initial Suppression       .335**           .033             -.010 
Step 3    .019     .009          .000 
Initial Reappraisal x       -.147           .101   .006 
 Initial Suppression 
 
 
Note. †Covariates included group status, race, education, treatment intensity and BMI. 
Significance indicators: ^ = < .10, * = ≤ .05, ** = ≤ .01. Circ_ = circulating. Stim_ =Stimulated. Ln= 







Figure 1. Distress levels as a function of time, as measured by months since diagnosis. On 














Figure 2. Circulating IL-6 levels as a function of time, as measured by months since diagnosis. 















Figure 3. Stimulated IL-6 levels as a function of time, as measured by months since diagnosis. 















Figure 4. Stimulated IL-6 levels as a function of time x suppression. Generally, higher 





















Figure 5. Individual trajectories for suppression and reappraisal for a subset of participants 
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